US Edition
NHS to Roll Out 'Suit of Armour' Jab for 'High Risk' Infants and Babies - Liverpool Echo
UNITED KINGDOM, JUL 18 – Nirsevimab offers over 80% protection and replaces monthly injections, benefiting about 9,000 premature babies across UK health systems this RSV season, reducing hospital admissions.
- Later this year, NHS England and its devolved counterparts will roll out nirsevimab, a single long-acting injection providing a 'protective bubble' against RSV for premature babies, NHS medics said.
- Lacking time to build antibodies, preterm infants face heightened RSV risks, NHS England reported, noting hospitalisation data and the vaccine gap.
- Offering immediate immunity, nirsevimab, a monoclonal antibody, replaces monthly palivizumab, providing over six months of RSV protection and passive immunity.
- NHS England estimates 95% uptake could prevent nearly 350 hospital admissions this year, while the programme will ease seasonal NHS pressures.
- About 9,000 infants will benefit annually, and the programme will extend through the RSV season from October to March, providing immediate passive immunity.
Insights by Ground AI
Does this summary seem wrong?
30 Articles
30 Articles
Measles hotspots mapped after child dies and UK 'redoubles efforts' to vaccinate - The Mirror
After a child died at Alder Hey Children’s Hospital in Liverpool, efforts have been stepped up as the government urge parents to increase their efforts to vaccinate children
·London, United Kingdom
Read Full Article
Coverage Details
Total News Sources30
Leaning Left8Leaning Right0Center7Last UpdatedBias Distribution53% Left
Bias Distribution
- 53% of the sources lean Left
53% Left
L 53%
C 47%
Factuality
To view factuality data please Upgrade to Premium
